| Financial Year |
March 31 2023 |
| Monetary Funds |
225,521,736.67 |
| Held-for-trading Financial Assets |
141,131,949.96 |
| Notes Receivable |
9,008,646.36 |
| Accounts Receivable |
561,609,181.24 |
| Advances to Suppliers |
170,994,291.71 |
| Other Receivables |
27,099,214.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
634,112,298.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
234,960,981.54 |
| Total Current Assets |
2,004,438,299.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
485,697,346.75 |
| Investment Properties |
15,548,338.78 |
| Fixed Assetes |
268,763,212.35 |
| Under-construction Projects |
40,065,508.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,733,816.39 |
| R&D expenses |
-- |
| Goodwill |
172,707,747.08 |
| Long-Term Deferred and Prepaid Expenses |
1,122,421.46 |
| Deferred Income Tax Assets |
28,008,718.37 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,121,666,722.67 |
| Total Assets |
3,126,105,022.44 |
| Short-Term Loans |
205,648,200.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,400,000.00 |
| Accounts Payable |
155,736,797.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,773,940.93 |
| Taxes Payable |
20,188,952.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,437,878.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,500,000.00 |
| Other Current Liabilities |
14,134,917.30 |
| Sub-Total of Current Liabilities |
551,569,473.99 |
| Long-term Loans |
8,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
83,486,500.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,798,075.50 |
| Other Non-Current Liabilities |
4,129,200.00 |
| Sub-Total of Non-Current Liabilities |
120,504,551.26 |
| Total Liabilities |
672,074,025.25 |
| Paid-In Capital(Or Share Stock) |
1,040,033,262.00 |
| Capital Surplus |
35,786,685.35 |
| Surplus Reserve |
166,619,125.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,002,593,924.44 |
| Minority Stockholder's Interest |
193,273,668.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,260,757,328.56 |
| Owner's Equity（Stockholder's Equity） |
2,454,030,997.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,126,105,022.44 |
